Global Bipolar Disorder Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 121 pages | ID: GBF0B3E130BEN
GlobalInfoResearch

Abstracts

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity levels.

SCOPE OF THE REPORT:

This report studies the Bipolar Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bipolar Disorder market by product type and applications/end industries.
People suffering with bipolar disorder have intense emotional states that occur in distinct periods called mood episodes. Mood episode is characterized by drastic changes in person?s usual mood and their behavior. Mood episode is mainly classified into two main types: manic episodes and depressive episodes. An overexcited or joyful state is called a manic episode and an extremely hopeless or sad state is called a depressive episode. Sometimes, a mood episode includes symptoms of both depression and mania, known as mixed state. These mood episodes hamper school and job performance.
The global Bipolar Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bipolar Disorder.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Glaxo SmithKline (GSK)
• Pfizer
• Janssen Pharmaceuticals
• Eli Lilly
• Allergan
• Novartis
• AbbVie
• Otsuka
• AstraZeneca

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Selective Serotonin Reuptake Inhibitor
• Serotonin Norepinephrine Reuptake Inhibitors
• Tricyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Benzodiazepines
• Beta Blockers

Market Segment by Applications, can be divided into

• Mood Stabilizers
• Anticonvulsants
• Antipsychotic drugs
• Antidepressant drugs
• Antianxiety drugs

Contents

1 BIPOLAR DISORDER MARKET OVERVIEW

1.1 Product Overview and Scope of Bipolar Disorder
1.2 Classification of Bipolar Disorder by Types
  1.2.1 Global Bipolar Disorder Revenue Comparison by Types (2017-2023)
  1.2.2 Global Bipolar Disorder Revenue Market Share by Types in 2017
  1.2.3 Selective Serotonin Reuptake Inhibitor
  1.2.4 Serotonin Norepinephrine Reuptake Inhibitors
  1.2.5 Tricyclic Antidepressants
  1.2.6 Monoamine Oxidase Inhibitors
  1.2.7 Benzodiazepines
  1.2.8 Beta Blockers
1.3 Global Bipolar Disorder Market by Application
  1.3.1 Global Bipolar Disorder Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Mood Stabilizers
  1.3.3 Anticonvulsants
  1.3.4 Antipsychotic drugs
  1.3.5 Antidepressant drugs
  1.3.6 Antianxiety drugs
1.4 Global Bipolar Disorder Market by Regions
  1.4.1 Global Bipolar Disorder Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Bipolar Disorder Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Bipolar Disorder Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bipolar Disorder Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Bipolar Disorder Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bipolar Disorder Status and Prospect (2013-2023)
1.5 Global Market Size of Bipolar Disorder (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Glaxo SmithKline (GSK)
  2.1.1 Business Overview
  2.1.2 Bipolar Disorder Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
  2.2.1 Business Overview
  2.2.2 Bipolar Disorder Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Pfizer Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Bipolar Disorder Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Janssen Pharmaceuticals Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
  2.4.1 Business Overview
  2.4.2 Bipolar Disorder Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Eli Lilly Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allergan
  2.5.1 Business Overview
  2.5.2 Bipolar Disorder Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Allergan Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
  2.6.1 Business Overview
  2.6.2 Bipolar Disorder Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Novartis Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.7 AbbVie
  2.7.1 Business Overview
  2.7.2 Bipolar Disorder Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 AbbVie Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.8 Otsuka
  2.8.1 Business Overview
  2.8.2 Bipolar Disorder Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Otsuka Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.9 AstraZeneca
  2.9.1 Business Overview
  2.9.2 Bipolar Disorder Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 AstraZeneca Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BIPOLAR DISORDER MARKET COMPETITION, BY PLAYERS

3.1 Global Bipolar Disorder Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Bipolar Disorder Players Market Share
  3.2.2 Top 10 Bipolar Disorder Players Market Share
3.3 Market Competition Trend

4 GLOBAL BIPOLAR DISORDER MARKET SIZE BY REGIONS

4.1 Global Bipolar Disorder Revenue and Market Share by Regions
4.2 North America Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.3 Europe Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.5 South America Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BIPOLAR DISORDER REVENUE BY COUNTRIES

5.1 North America Bipolar Disorder Revenue by Countries (2013-2018)
5.2 USA Bipolar Disorder Revenue and Growth Rate (2013-2018)
5.3 Canada Bipolar Disorder Revenue and Growth Rate (2013-2018)
5.4 Mexico Bipolar Disorder Revenue and Growth Rate (2013-2018)

6 EUROPE BIPOLAR DISORDER REVENUE BY COUNTRIES

6.1 Europe Bipolar Disorder Revenue by Countries (2013-2018)
6.2 Germany Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.3 UK Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.4 France Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.5 Russia Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.6 Italy Bipolar Disorder Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BIPOLAR DISORDER REVENUE BY COUNTRIES

7.1 Asia-Pacific Bipolar Disorder Revenue by Countries (2013-2018)
7.2 China Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.3 Japan Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.4 Korea Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.5 India Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bipolar Disorder Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BIPOLAR DISORDER REVENUE BY COUNTRIES

8.1 South America Bipolar Disorder Revenue by Countries (2013-2018)
8.2 Brazil Bipolar Disorder Revenue and Growth Rate (2013-2018)
8.3 Argentina Bipolar Disorder Revenue and Growth Rate (2013-2018)
8.4 Colombia Bipolar Disorder Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BIPOLAR DISORDER BY COUNTRIES

9.1 Middle East and Africa Bipolar Disorder Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.3 UAE Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.4 Egypt Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.6 South Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)

10 GLOBAL BIPOLAR DISORDER MARKET SEGMENT BY TYPE

10.1 Global Bipolar Disorder Revenue and Market Share by Type (2013-2018)
10.2 Global Bipolar Disorder Market Forecast by Type (2018-2023)
10.3 Selective Serotonin Reuptake Inhibitor Revenue Growth Rate (2013-2023)
10.4 Serotonin Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2023)
10.5 Tricyclic Antidepressants Revenue Growth Rate (2013-2023)
10.6 Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2023)
10.7 Benzodiazepines Revenue Growth Rate (2013-2023)
10.8 Beta Blockers Revenue Growth Rate (2013-2023)

11 GLOBAL BIPOLAR DISORDER MARKET SEGMENT BY APPLICATION

11.1 Global Bipolar Disorder Revenue Market Share by Application (2013-2018)
11.2 Bipolar Disorder Market Forecast by Application (2018-2023)
11.3 Mood Stabilizers Revenue Growth (2013-2018)
11.4 Anticonvulsants Revenue Growth (2013-2018)
11.5 Antipsychotic drugs Revenue Growth (2013-2018)
11.6 Antidepressant drugs Revenue Growth (2013-2018)
11.7 Antianxiety drugs Revenue Growth (2013-2018)

12 GLOBAL BIPOLAR DISORDER MARKET SIZE FORECAST (2018-2023)

12.1 Global Bipolar Disorder Market Size Forecast (2018-2023)
12.2 Global Bipolar Disorder Market Forecast by Regions (2018-2023)
12.3 North America Bipolar Disorder Revenue Market Forecast (2018-2023)
12.4 Europe Bipolar Disorder Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bipolar Disorder Revenue Market Forecast (2018-2023)
12.6 South America Bipolar Disorder Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bipolar Disorder Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Bipolar Disorder Picture
Table Product Specifications of Bipolar Disorder
Table Global Bipolar Disorder and Revenue (Million USD) Market Split by Product Type
Figure Global Bipolar Disorder Revenue Market Share by Types in 2017
Figure Selective Serotonin Reuptake Inhibitor Picture
Figure Serotonin Norepinephrine Reuptake Inhibitors Picture
Figure Tricyclic Antidepressants Picture
Figure Monoamine Oxidase Inhibitors Picture
Figure Benzodiazepines Picture
Figure Beta Blockers Picture
Table Global Bipolar Disorder Revenue (Million USD) by Application (2013-2023)
Figure Bipolar Disorder Revenue Market Share by Applications in 2017
Figure Mood Stabilizers Picture
Figure Anticonvulsants Picture
Figure Antipsychotic drugs Picture
Figure Antidepressant drugs Picture
Figure Antianxiety drugs Picture
Table Global Market Bipolar Disorder Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Bipolar Disorder Revenue (Million USD) and Growth Rate (2013-2023)
Table Glaxo SmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table Glaxo SmithKline (GSK) Bipolar Disorder Type and Applications
Table Glaxo SmithKline (GSK) Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Bipolar Disorder Type and Applications
Table Pfizer Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals Bipolar Disorder Type and Applications
Table Janssen Pharmaceuticals Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Bipolar Disorder Type and Applications
Table Eli Lilly Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Bipolar Disorder Type and Applications
Table Allergan Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Bipolar Disorder Type and Applications
Table Novartis Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Bipolar Disorder Type and Applications
Table AbbVie Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Bipolar Disorder Type and Applications
Table Otsuka Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Bipolar Disorder Type and Applications
Table AstraZeneca Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
Table Global Bipolar Disorder Revenue (Million USD) by Players (2013-2018)
Table Global Bipolar Disorder Revenue Share by Players (2013-2018)
Figure Global Bipolar Disorder Revenue Share by Players in 2016
Figure Global Bipolar Disorder Revenue Share by Players in 2017
Figure Global Top 5 Players Bipolar Disorder Revenue Market Share in 2017
Figure Global Top 10 Players Bipolar Disorder Revenue Market Share in 2017
Figure Global Bipolar Disorder Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Bipolar Disorder Revenue (Million USD) by Regions (2013-2018)
Table Global Bipolar Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Bipolar Disorder Revenue Market Share by Regions (2013-2018)
Figure Global Bipolar Disorder Revenue Market Share by Regions in 2017
Figure North America Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Europe Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure South America Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table North America Bipolar Disorder Revenue by Countries (2013-2018)
Table North America Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure North America Bipolar Disorder Revenue Market Share by Countries in 2017
Figure USA Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Canada Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Mexico Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table Europe Bipolar Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Europe Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure Europe Bipolar Disorder Revenue Market Share by Countries in 2017
Figure Germany Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure UK Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure France Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Russia Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Italy Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Bipolar Disorder Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Bipolar Disorder Revenue Market Share by Countries in 2017
Figure China Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Japan Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Korea Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure India Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table South America Bipolar Disorder Revenue by Countries (2013-2018)
Table South America Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure South America Bipolar Disorder Revenue Market Share by Countries in 2017
Figure Brazil Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Argentina Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Colombia Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Bipolar Disorder Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Bipolar Disorder Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Bipolar Disorder Revenue Market Share by Countries in 2017
Figure Saudi Arabia Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure UAE Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Egypt Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure Nigeria Bipolar Disorder Revenue and Growth Rate (2013-2018)
Figure South Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)
Table Global Bipolar Disorder Revenue (Million USD) by Type (2013-2018)
Table Global Bipolar Disorder Revenue Share by Type (2013-2018)
Figure Global Bipolar Disorder Revenue Share by Type (2013-2018)
Figure Global Bipolar Disorder Revenue Share by Type in 2017
Table Global Bipolar Disorder Revenue Forecast by Type (2018-2023)
Figure Global Bipolar Disorder Market Share Forecast by Type (2018-2023)
Figure Global Selective Serotonin Reuptake Inhibitor Revenue Growth Rate (2013-2018)
Figure Global Serotonin Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Tricyclic Antidepressants Revenue Growth Rate (2013-2018)
Figure Global Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Benzodiazepines Revenue Growth Rate (2013-2018)
Figure Global Beta Blockers Revenue Growth Rate (2013-2018)
Table Global Bipolar Disorder Revenue by Application (2013-2018)
Table Global Bipolar Disorder Revenue Share by Application (2013-2018)
Figure Global Bipolar Disorder Revenue Share by Application (2013-2018)
Figure Global Bipolar Disorder Revenue Share by Application in 2017
Table Global Bipolar Disorder Revenue Forecast by Application (2018-2023)
Figure Global Bipolar Disorder Market Share Forecast by Application (2018-2023)
Figure Global Mood Stabilizers Revenue Growth Rate (2013-2018)
Figure Global Anticonvulsants Revenue Growth Rate (2013-2018)
Figure Global Antipsychotic drugs Revenue Growth Rate (2013-2018)
Figure Global Antidepressant drugs Revenue Growth Rate (2013-2018)
Figure Global Antianxiety drugs Revenue Growth Rate (2013-2018)
Figure Global Bipolar Disorder Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Bipolar Disorder Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Bipolar Disorder Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Bipolar Disorder Revenue Market Forecast (2018-2023)
Figure Europe Bipolar Disorder Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Bipolar Disorder Revenue Market Forecast (2018-2023)
Figure South America Bipolar Disorder Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Bipolar Disorder Revenue Market Forecast (2018-2023)